Evolution of pneumococcal serotype 19A in children in Bangladesh: insights from genomic analysis

Arif Mohammad Tanmoy1, Esha Kazi1, Naito Kanon1

  • 1Child Health Research Foundation, Dhaka, Bangladesh.

BMC Microbiology
|November 25, 2025
PubMed

Insights

Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae serotype 19A did not increase in Bangladeshi children after PCV10 vaccine introduction. Continuous genomic surveillance is crucial due to evolving local 19A strains and increasing macrolide resistance.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae is a significant global health threat, especially for children.
  • Serotype 19A is noted for multidrug resistance (MDR) and increased incidence post-vaccine introduction in many regions.
  • Bangladesh introduced the 10-valent pneumococcal conjugate vaccine (PCV10) in 2015, anticipating a low burden of serotype 19A.

Purpose of the Study:

  • To investigate the hospital incidence of serotype 19A in children under five years old in Bangladesh before and after PCV10 introduction.
  • To conduct a comprehensive genomic analysis of serotype 19A isolates to understand population structure, antimicrobial resistance, and evolutionary dynamics.
  • To assess the impact of PCV10 introduction on the prevalence of specific 19A lineages and their resistance patterns.

Main Methods:

  • Longitudinal IPD surveillance data from 2004 to 2023 were analyzed for hospital incidence trends of serotype 19A.
  • Whole-genome sequencing was performed on 153 serotype 19A isolates from various sample types (IPD, otitis media, carriage, urine).
  • Phylogenetic and Bayesian Evolutionary Analysis Sampling Trees (BEAST) analyses were employed to determine population structure, global pneumococcal sequence clusters (GPSCs), sequence types (STs), and antimicrobial resistance genes, comparing them with global 19A genomes.

Main Results:

  • No increase in hospital IPD incidence due to serotype 19A was observed post-PCV10 introduction.
  • The multidrug-resistant 19A-ST320 lineage (GPSC1) was notably absent in Bangladesh.
  • A new dominant lineage, ST12888 (GPSC84) carrying the 19A subtype-I (19A-I) capsular locus, emerged and increased from 15% to 70% post-PCV10 introduction.
  • Increasing macrolide resistance was detected within the 19A-I/GPSC84 lineage, with estimated origins between 2007 and 2011.

Conclusions:

  • The study supports Bangladesh's decision to implement PCV10 based on pre-vaccination serotype burden data.
  • The emergence and rapid spread of the 19A-I/GPSC84 lineage highlight the dynamic nature of pneumococcal populations.
  • Continuous epidemiological and genomic surveillance is essential for monitoring vaccine effectiveness and adapting public health strategies against evolving Streptococcus pneumoniae strains.
Abstract

Related Concept Videos

Evolution of Microbial Genome01:08

Evolution of Microbial Genome

Microbial genome evolution is a highly dynamic process shaped by continual gene gain and loss across species and strains. This genomic flexibility allows microorganisms to adapt rapidly to environmental pressures and interactions with other organisms. Central to understanding this diversity is the distinction between the core and pan genomes.The core genome comprises the genes shared by all sampled strains of a species, representing essential functions needed for fundamental cellular processes.
116
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
88
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245